相关实验视频

Updated: Jan 16, 2026

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

韩国队列中的CYP2D6基因型定型:与亚洲,高加索和非洲人群进行比较分析

Tak Don Kim^1,2, Jung-Sook Kwak³, Jae-Gook Shin^3,4

¹Clinical Trials Centre, Chungnam National University Hospital, Daejeon, Republic of Korea.

Pharmacogenomics

|September 26, 2025

概括

这项研究详细介绍了对韩国人的细胞染色体P450 2D6 (CYP2D6) 遗传变异的最大分析. 研究结果揭示了显著的等位基因分布和表型,这对于这个人群的个性化医学至关重要.

科学领域:

药物基因组学药物基因组学
药物新陈代谢药物新陈代谢
人类遗传学人类遗传学

背景情况:

细胞染色体P450 2D6 (CYP2D6) 是药物代谢中的关键酶,具有显著的遗传变异性.
这种变异性影响药物反应,并导致个人间和种族间的差异.
关于韩国人口中CYP2D6等位基因频率的有限大规模数据存在.

研究的目的:

在一个大规模的韩国队列中对CYP2D6等位基因分布和表型进行全面分析.
为韩国药物基因组学建立一个参考.
通过了解特定人群的遗传变异来告知个性化医学策略.

主要方法:

对3,874名非相关的韩国人进行了CYP2D6基因型鉴定,包括副本数变异分析.
用CPIC活动评分系统确定基因型并将其分为双型和表型.

主要成果:

最常见的等位基因是CYP2D6*10 (44.9%),其次是*1 (32.8%) 和*2 (11.0%).
基因删除 (*5) 占5.7%的等位基因.
现型分布包括62.2%的广泛代谢者,36.1%的中间代谢者,0.9%的超快代谢者和0.4%的低代谢者.
在韩国人身上发现了以前未报告的CYP2D6*65和一种新的重复变异CYP2D6*49x2.

结论:

这项研究是迄今为止对韩国人的CYP2D6多态性最大的调查.
这些发现为韩国人口提供了重要的药物基因组数据,并突出了种族间的差异.
结果支持实施针对特定人群遗传特征量身定制的个性化医学方法.

关键词:

这种类型的等位基因是:在CYP2D6中.在CYP450的基础上.药物不良反应药物不良反应副本编号的变体变体.种族差异是种族差异.民族药物反应的民族药物反应基因型基因型基因型

更多相关视频

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

相关概念视频

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Karyotyping

Karyotyping

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...